<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Pyrazinamid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:09 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Pyrazinamid_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Pyrazinamid_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Pyrazinamid_files/filelist.xml">
<title>PYRAZINAMID</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-08-08T14:09:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:28:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1088</o:Words>
  <o:Characters>6205</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>51</o:Lines>
  <o:Paragraphs>14</o:Paragraphs>
  <o:CharactersWithSpaces>7279</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>PYRAZINAMID<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'> Pyrazinamide.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Mã ATC:</span></b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;letter-spacing:-.2pt'> J04A K01.</span><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'><o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Lo&#7841;i thu&#7889;c:</span></b><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana;letter-spacing:
-.2pt'> Thu&#7889;c ch&#7889;ng lao.</span><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng dùng và hàm l&#432;&#7907;ng
<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Viên nén 0,5 g pyrazinamid.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid là m&#7897;t thu&#7889;c trong &#273;a hóa tr&#7883; li&#7879;u
ch&#7889;ng lao, ch&#7911; y&#7871;u dùng trong 8 tu&#7847;n &#273;&#7847;u c&#7911;a
hóa tr&#7883; li&#7879;u ng&#7855;n ngày. Pyrazinamid có tác d&#7909;ng di&#7879;t
tr&#7921;c khu&#7849;n lao (<i>Mycobacterium tuberculosis</i>), nh&#432;ng
không có tác d&#7909;ng v&#7899;i các <i>Mycobacterium</i> khác ho&#7863;c các
vi khu&#7849;n khác in vitro. N&#7891;ng &#273;&#7897; t&#7889;i thi&#7875;u &#7913;c
ch&#7871; tr&#7921;c khu&#7849;n lao là d&#432;&#7899;i 20 microgam/ml &#7903;
pH 5,6; thu&#7889;c h&#7847;u nh&#432; không tác d&#7909;ng &#7903; pH trung
tính.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid có tác d&#7909;ng v&#7899;i tr&#7921;c khu&#7849;n lao
&#273;ang t&#7891;n t&#7841;i trong môi tr&#432;&#7901;ng n&#7897;i bào có tính
acid c&#7911;a &#273;&#7841;i th&#7921;c bào. Ðáp &#7913;ng viêm ban &#273;&#7847;u
v&#7899;i hóa tr&#7883; li&#7879;u làm t&#259;ng s&#7889; vi khu&#7849;n trong
môi tr&#432;&#7901;ng acid. Khi &#273;áp &#7913;ng viêm gi&#7843;m và pH
t&#259;ng thì ho&#7841;t tính di&#7879;t khu&#7849;n c&#7911;a pyrazinamid gi&#7843;m.
Tác d&#7909;ng ph&#7909; thu&#7897;c vào pH gi&#7843;i thích hi&#7879;u l&#7921;c
lâm sàng c&#7911;a thu&#7889;c trong giai &#273;o&#7841;n 8 tu&#7847;n &#273;&#7847;u
hóa tr&#7883; li&#7879;u ng&#7855;n ngày. Tr&#7921;c khu&#7849;n lao kháng thu&#7889;c
nhanh khi dùng pyrazinamid &#273;&#417;n &#273;&#7897;c.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid &#273;&#432;&#7907;c h&#7845;p thu t&#7889;t qua
&#273;&#432;&#7901;ng tiêu hóa. N&#7891;ng &#273;&#7897; &#273;&#7881;nh trong
huy&#7871;t thanh &#273;&#7841;t &#273;&#432;&#7907;c 2 gi&#7901; sau khi u&#7889;ng
m&#7897;t li&#7873;u 1,5 g là kho&#7843;ng 35 microgam/ml và v&#7899;i li&#7873;u
3 g là 66 microgam/ml. Thu&#7889;c phân b&#7889; vào các mô và d&#7883;ch c&#7911;a
c&#417; th&#7875; k&#7875; c&#7843; gan, ph&#7893;i, d&#7883;ch não t&#7911;y.
N&#7891;ng &#273;&#7897; thu&#7889;c trong d&#7883;ch não t&#7911;y
t&#432;&#417;ng &#273;&#432;&#417;ng v&#7899;i n&#7891;ng &#273;&#7897; &#7893;n
&#273;&#7883;nh trong huy&#7871;t t&#432;&#417;ng &#7903; nh&#7919;ng ng&#432;&#7901;i
b&#7879;nh viêm màng não. Pyrazinamid g&#7855;n v&#7899;i protein huy&#7871;t
t&#432;&#417;ng kho&#7843;ng 10%.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.2pt'>N&#7917;a &#273;&#7901;i sinh h&#7885;c (t1/2) c&#7911;a
thu&#7889;c là 9 - 10 gi&#7901;, dài h&#417;n khi b&#7883; suy th&#7853;n ho&#7863;c
suy gan. Pyrazinamid b&#7883; th&#7911;y phân &#7903; gan thành ch&#7845;t chuy&#7875;n
hóa chính có ho&#7841;t tính là acid pyrazinoic, ch&#7845;t này sau &#273;ó b&#7883;
hydroxyl hóa thành acid 5 - hydroxy pyrazinoic. Thu&#7889;c &#273;ào th&#7843;i
qua th&#7853;n, ch&#7911; y&#7871;u do l&#7885;c &#7903; c&#7847;u th&#7853;n.
Kho&#7843;ng 70% li&#7873;u u&#7889;ng &#273;ào th&#7843;i trong vòng 24 gi&#7901;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881; &#273;&#7883;nh <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; lao m&#7899;i ch&#7849;n &#273;oán ho&#7863;c tái
tr&#7883; b&#7879;nh lao ph&#7893;i và ngoài ph&#7893;i, ch&#7911; y&#7871;u &#7903;
giai &#273;o&#7841;n t&#7845;n công ban &#273;&#7847;u, th&#432;&#7901;ng ph&#7889;i
h&#7907;p v&#7899;i isoniazid và rifampicin theo Hi&#7879;p h&#7897;i ch&#7889;ng
lao và b&#7879;nh ph&#7893;i th&#7871; gi&#7899;i (IUATLD) và t&#7893; ch&#7913;c
y t&#7871; th&#7871; gi&#7899;i (WHO) (Ch&#432;&#417;ng trình ch&#7889;ng lao
Vi&#7879;t Nam: Pyrazinamid th&#432;&#7901;ng ph&#7889;i h&#7907;p v&#7899;i
isoniazid, streptomycin và rifampicin).<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh
<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>T&#7893;n th&#432;&#417;ng gan n&#7863;ng, lo&#7841;n chuy&#7875;n hóa
porphyrin, m&#7851;n c&#7843;m v&#7899;i thu&#7889;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n tr&#7885;ng <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ng&#432;&#7901;i b&#7879;nh có ti&#7873;n s&#7917; &#273;ái tháo
&#273;&#432;&#7901;ng (khó ki&#7875;m soát b&#7879;nh &#273;ái tháo
&#273;&#432;&#7901;ng khi dùng pyrazinamid), viêm kh&#7899;p, ti&#7873;n s&#7917;
b&#7879;nh gút (tránh dùng khi có c&#417;n c&#7845;p tính) c&#7845;p, suy th&#7853;n
(nhà s&#7843;n xu&#7845;t g&#7907;i ý có th&#7875; c&#7847;n ph&#7843;i gi&#7843;m
li&#7873;u &#7903; ng&#432;&#7901;i có t&#7893;n th&#432;&#417;ng th&#7853;n). <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có th&#7875; dùng pyrazinamid cho ng&#432;&#7901;i mang thai, ph&#7889;i
h&#7907;p v&#7899;i rifampicin và isoniazid.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid ti&#7871;t vào s&#7919;a m&#7865; v&#7899;i l&#432;&#7907;ng
nh&#7887;, ng&#432;&#7901;i m&#7865; cho con bú có th&#7875; dùng pyrazinamid.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ph&#7843;n &#7913;ng có h&#7841;i thông th&#432;&#7901;ng nh&#7845;t
là gây &#273;&#7897;c cho gan và ph&#7909; thu&#7897;c vào li&#7873;u dùng.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Th&#432;&#7901;ng g&#7863;p, ADR &gt; 1/100<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Gan: Viêm gan<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Chuy&#7875;n hóa: T&#259;ng acid uric máu có th&#7875; gây c&#417;n
gút.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>X&#432;&#417;ng, kh&#7899;p: Ðau các kh&#7899;p l&#7899;n và nh&#7887;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Kh&#7899;p x&#432;&#417;ng: Viêm kh&#7899;p<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Hi&#7871;m g&#7863;p, ADR &lt;1/1000<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Tiêu hóa: Bu&#7891;n nôn, nôn, chán &#259;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Chuy&#7875;n hóa: Lo&#7841;n chuy&#7875;n hóa porphyrin.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ti&#7871;t ni&#7879;u: Khó ti&#7875;u ti&#7879;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Da: M&#7851;n c&#7843;m ánh sáng, ng&#7913;a, phát ban.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng d&#7851;n cách x&#7917;
trí ADR<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>C&#7847;n ki&#7875;m tra ch&#7913;c n&#259;ng gan tr&#432;&#7899;c, trong
và sau khi &#273;i&#7873;u tr&#7883; v&#7899;i pyrazinamid. N&#7871;u có d&#7845;u
hi&#7879;u t&#7893;n th&#432;&#417;ng gan n&#7863;ng, ph&#7843;i ng&#7915;ng
dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và
cách dùng <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Li&#7873;u l&#432;&#7907;ng: </span></i><span style='font-size:9.0pt;
mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Cho c&#7843;
ng&#432;&#7901;i l&#7899;n và tr&#7867; em.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>25 mg/kg/ngày (20 - 30 mg/kg/ngày) khi &#273;i&#7873;u
tr&#7883; h&#7857;ng ngày.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>35 mg/kg/ngày (30 - 40 mg/kg/ngày) khi &#273;i&#7873;u
tr&#7883; cách quãng, tu&#7847;n 3 ngày. ít &#273;&#432;&#7907;c s&#7917; d&#7909;ng
và khuy&#7871;n cáo.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>50 mg/kg/ngày (40 - 60 mg/kg/ngày) khi &#273;i&#7873;u
tr&#7883; cách quãng, tu&#7847;n 2 l&#7847;n (cách 2 ngày). R&#7845;t ít
&#273;&#432;&#7907;c s&#7917; d&#7909;ng và không &#273;&#432;&#7907;c khuy&#7871;n
cáo trong các công th&#7913;c &#273;i&#7873;u tr&#7883; c&#7911;a WHO.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Cách dùng<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>Ð&#7875; tránh tr&#7921;c khu&#7849;n &#273;&#7897;t
bi&#7871;n kháng thu&#7889;c trong &#273;i&#7873;u tr&#7883; b&#7879;nh lao,
không bao gi&#7901; ch&#7881; dùng m&#7897;t lo&#7841;i thu&#7889;c
(&#273;&#417;n tr&#7883; li&#7879;u) mà ph&#7843;i có s&#7921; ph&#7889;i h&#7907;p
pyrazinamid v&#7899;i các thu&#7889;c có tác d&#7909;ng khác, nh&#7845;t là
trong giai &#273;o&#7841;n &#273;i&#7873;u tr&#7883; t&#7845;n công ban &#273;&#7847;u.
Ði&#7873;u tr&#7883; b&#7879;nh lao có 2 giai &#273;o&#7841;n: giai &#273;o&#7841;n
t&#7845;n công ban &#273;&#7847;u (th&#432;&#7901;ng là 2 tháng, có khi 3
tháng) và ti&#7871;p ngay sau &#273;ó là giai &#273;o&#7841;n duy trì (th&#432;&#7901;ng
là 4 - 5 ho&#7863;c 6 tháng). Hi&#7879;n nay, WHO &#273;&#7873; ra cho các
Ch&#432;&#417;ng trình ch&#7889;ng lao qu&#7889;c gia m&#7897;t s&#7889; công
th&#7913;c &#273;i&#7873;u tr&#7883; lao. T&#7915;ng Ch&#432;&#417;ng trình ch&#7889;ng
lao qu&#7889;c gia, tùy theo tình hình b&#7879;nh t&#7853;t, kh&#7843;
n&#259;ng cung &#7913;ng c&#7911;a ngân sách qu&#7889;c gia, tình hình trang
thi&#7871;t b&#7883; y t&#7871; và t&#7893; ch&#7913;c m&#7841;ng l&#432;&#7899;i
ch&#7889;ng lao c&#7911;a n&#432;&#7899;c mình mà l&#7921;a ch&#7885;n dùng nh&#7919;ng
công th&#7913;c thích h&#7907;p. Các công th&#7913;c &#273;ó là: <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>2 EHRZ (SHRZ)/6 HE ho&#7863;c 2 EHRZ (SHRZ)/4 HR
ho&#7863;c 2 EHRZ (SHRZ)/4 H<sub>3</sub>R<sub>3</sub> dùng cho lao m&#7899;i
&#273;&#432;&#7907;c phát hi&#7879;n và &#273;i&#7873;u tr&#7883; l&#7847;n
&#273;&#7847;u: lao ph&#7893;i, &#273;&#7901;m BK soi tr&#7921;c ti&#7871;p
(+), lao ph&#7893;i, &#273;&#7901;m BK soi tr&#7921;c ti&#7871;p ( - )
nh&#432;ng di&#7879;n t&#7893;n th&#432;&#417;ng r&#7897;ng và lao ngoài ph&#7893;i
th&#7875; n&#7863;ng.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>2 HRZ/6 HE ho&#7863;c 2 HRZ/4 HR ho&#7863;c 2
HRZ/4 H<sub>3</sub>R<sub>3</sub> dùng cho lao ph&#7893;i m&#7899;i &#273;&#432;&#7907;c
phát hi&#7879;n, &#273;&#7901;m BK soi tr&#7921;c ti&#7871;p ( - ) di&#7879;n t&#7893;n
th&#432;&#417;ng h&#7865;p và lao ngoài ph&#7893;i th&#7875; nh&#7865;.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>2 SHRZE/1 HRZE/5 H<sub>3</sub>R<sub>3</sub>E<sub>3</sub>
ho&#7863;c 2 SHRZE/1 HRZE/5 HRE dùng cho nh&#7919;ng tr&#432;&#7901;ng h&#7907;p
&#273;i&#7873;u tr&#7883; th&#7845;t b&#7841;i, b&#7887; d&#7903; &#273;i&#7873;u
tr&#7883; ho&#7863;c tái phát khi &#273;ã &#273;&#432;&#7907;c dùng m&#7897;t
trong các công th&#7913;c &#273;i&#7873;u tr&#7883; l&#7847;n &#273;&#7847;u.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana;letter-spacing:-.1pt'>&#7903; Vi&#7879;t Nam, ch&#432;&#417;ng trình ch&#7889;ng
lao qu&#7889;c gia &#273;ã và &#273;ang dùng công th&#7913;c 2 SHRZ/6 HE &#273;&#7875;
&#273;i&#7873;u tr&#7883; lao m&#7899;i phát hi&#7879;n và công th&#7913;c 2
SHRZE/1 HRZE/5 H<sub>3</sub>R<sub>3</sub>E<sub>3</sub> &#273;&#7875; &#273;i&#7873;u
tr&#7883; lao th&#7845;t b&#7841;i ho&#7863;c tái phát. Công th&#7913;c 2 HRZ/4
HR &#273;&#432;&#7907;c dùng &#273;i&#7873;u tr&#7883; lao tr&#7867; em,
nh&#432;ng &#273;&#7889;i v&#7899;i th&#7875; n&#7863;ng có th&#7875; b&#7893;
sung thêm S vào giai &#273;o&#7841;n t&#7845;n công ban &#273;&#7847;u.<o:p></o:p></span></p>

<p class=5 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ghi chú:<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Có m&#7897;t mã chu&#7849;n dùng cho các công th&#7913;c &#273;i&#7873;u
tr&#7883; lao. M&#7895;i thu&#7889;c ch&#7889;ng lao có m&#7897;t tên vi&#7871;t
t&#7855;t b&#7857;ng ch&#7919; cái: H = isoniazid, R = rifampicin, S =
Streptomycin, Z = pyrazinamid, E = ethambutol. M&#7897;t công th&#7913;c có 2
giai &#273;o&#7841;n. Con s&#7889; &#273;&#7913;ng tr&#432;&#7899;c m&#7897;t
giai &#273;o&#7841;n là th&#7901;i gian c&#7911;a giai &#273;o&#7841;n &#273;ó
tính b&#7857;ng tháng. Con s&#7889; &#273;&#7913;ng d&#432;&#7899;i và sau m&#7897;t
ch&#7919; cái là s&#7889; l&#7847;n dùng thu&#7889;c &#273;ó trong m&#7897;t tu&#7847;n.
N&#7871;u không có con s&#7889; nào &#273;&#7913;ng d&#432;&#7899;i và sau m&#7897;t
ch&#7919; cái thì thu&#7889;c &#273;ó &#273;&#432;&#7907;c dùng &#273;i&#7873;u
tr&#7883; hàng ngày. Các thu&#7889;c &#273;&#7875; l&#7921;a ch&#7885;n dùng
thay th&#7871; &#273;&#432;&#7907;c bi&#7875;u th&#7883; b&#7857;ng ch&#7919;
cái &#7903; trong các ngo&#7863;c &#273;&#417;n.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>D&#7845;u &quot;/&quot; phân cách các giai &#273;o&#7841;n &#273;i&#7873;u
tr&#7883; (giai &#273;o&#7841;n &#273;i&#7873;u tr&#7883; t&#7845;n công ban
&#273;&#7847;u và giai &#273;o&#7841;n &#273;i&#7873;u tr&#7883; duy trì c&#7911;ng
c&#7889;).<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><i><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ði&#7873;u tr&#7883; lao tr&#7921;c khu&#7849;n &#273;a kháng thu&#7889;c:
<o:p></o:p></span></i></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Khi kháng thu&#7889;c &#273;&#432;&#7907;c xác &#273;&#7883;nh ho&#7863;c
nghi ng&#7901; là nguyên nhân c&#7911;a th&#7845;t b&#7841;i &#273;i&#7873;u tr&#7883;,
vi&#7879;c tái tr&#7883; có giám sát h&#7857;ng ngày trong ít nh&#7845;t 12
tháng v&#7899;i ít nh&#7845;t 3 thu&#7889;c mà vi khu&#7849;n nh&#7841;y c&#7843;m
&#273;ã &#273;&#432;&#7907;c IUATLD &#273;&#7873; xu&#7845;t. Ít nh&#7845;t có
3 thu&#7889;c &#273;&#432;&#7907;c ch&#7885;n mà ng&#432;&#7901;i b&#7879;nh
ch&#432;a dùng ho&#7863;c không có s&#7921; kháng chéo v&#7899;i nh&#7919;ng
thu&#7889;c &#273;ã dùng tr&#432;&#7899;c &#273;ó. Có s&#7921; kháng chéo x&#7843;y
ra gi&#7919;a kanamycin, viomycin v&#7899;i capreomycin và gi&#7919;a
thioacetazon v&#7899;i prothionamid ho&#7863;c ethionamid.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid làm t&#259;ng acid uric huy&#7871;t và làm gi&#7843;m hi&#7879;u
qu&#7843; c&#7911;a các thu&#7889;c tr&#7883; b&#7879;nh gút nh&#432; <span
style='letter-spacing:-.2pt'>allopurinol, </span>colchicin, probenecid,
sulfinpyrazon. C&#7847;n &#273;i&#7873;u ch&#7881;nh li&#7873;u c&#7911;a các
thu&#7889;c này &#273;&#7875; &#273;i&#7873;u tr&#7883; t&#259;ng acid uric huy&#7871;t
và b&#7879;nh gút khi chúng &#273;&#432;&#7907;c dùng &#273;&#7891;ng th&#7901;i
v&#7899;i pyrazinamid.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid làm gi&#7843;m n&#7891;ng &#273;&#7897; ciclosporin khi
dùng &#273;&#7891;ng th&#7901;i. Ph&#7843;i theo dõi n&#7891;ng &#273;&#7897;
ciclosporin trong huy&#7871;t thanh.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u và x&#7917; trí <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Bi&#7875;u hi&#7879;n: Các k&#7871;t qu&#7843; xét nghi&#7879;m ch&#7913;c
n&#259;ng gan b&#7845;t th&#432;&#7901;ng, nh&#432; SGOT, SGPT t&#259;ng.
T&#259;ng t&#7921; phát này tr&#7903; l&#7841;i bình th&#432;&#7901;ng khi ng&#7915;ng
dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>X&#7917; trí: R&#7917;a d&#7841; dày, &#273;i&#7873;u tr&#7883; h&#7895;
tr&#7907;. Có th&#7875; th&#7849;m phân &#273;&#7875; lo&#7841;i b&#7887;
pyrazinamid.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;line-height:150%'><span style='mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Thông tin qui ch&#7871; <o:p></o:p></span></p>

<p class=2 align=left style='text-align:left;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Pyrazinamid có trong danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u
Vi&#7879;t Nam ban hành l&#7847;n th&#7913; t&#432; n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Pyrazinamid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:09 GMT -->
</html>
